Clinical approval for olacetam, a 6-class chemical of qingyutang pharmaceutical
-
Last Update: 2015-02-05
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Fu'an pharmaceutical announced today that its subsidiary, qingyutang pharmaceutical's olacetam capsule, recently received the approval for clinical trials of drugs issued by the State Food and drug administration It is understood that oxiracetam is a drug for nervous system diseases, which is mainly applicable to memory and intelligence disorders caused by mild to moderate vascular dementia, Alzheimer's disease and brain injury Fuan pharmaceutical also announced that qingyutang has received the notice of acceptance of drug registration from Chongqing food and Drug Administration: according to the measures for the administration of drug registration, after formal examination, the application materials of amoxicillin sodium for injection and flucloxicillin sodium for production are in line with the relevant provisions of the drug registration administration act, and it agrees to accept The data show that amoxicillin sodium for injection and flucloxicillin sodium are mainly suitable for respiratory tract infection, digestive tract infection, urinary tract infection, skin and soft tissue infection, bone and joint infection, oral and otorhinolaryngologic infection caused by sensitive bacteria.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
